Delivery Order 75F40121D00012-75F40123F19003

Award Date 11/7/22
Potential Completion Date 4/29/23
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jamaica, NY 11433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a $344,480.44 delivery order contract to Biomerieux Inc. for the annual maintenance and repair of the agency's fleet of Vitek and Vidas equipment. The firm fixed price contract runs from October 2, 2022 through April 29, 2024 and will be performed by Biomerieux Inc.'s division in Winchester, Massachusetts. Biomerieux Inc. will provide maintenance and repair services for the Food and Drug Administration's...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $326,934.76 delivery order contract to Biomerieux Inc. for the maintenance of Vitek and VIDAS instruments within ORA laboratories. The firm fixed price contract runs from April 26, 2022 to April 29, 2023 and will be performed in Takoma Park, Maryland. Biomerieux Inc. will provide maintenance services for their Vitek and VIDAS laboratory instruments to support the operations of laboratories within the...
Biomerieux Inc. was awarded a $31,995.61 firm fixed price delivery order against an unspecified contract vehicle to provide BIOMERIEUX VIDAS AND VITEK INSTRUMENTS for a single delivery to the Department of Health and Human Services Food and Drug Administration facility located in Eno Valley, North Carolina. The period of performance is through July 28, 2026 with no set-aside designation. As the leading provider of diagnostic solutions for use in clinical microbiology and infectious disease...
This is a firm-fixed-price delivery order issued under Contract 75F40121D0021 to Biomerieux Inc., a global leader in in vitro diagnostics, for the procurement of VITEK/VIDAS kits for the Food and Drug Administration (FDA) in fiscal year 2024, quarters 1 through 4. The order has a ceiling value of $64,345.68 and an ultimate completion date of November 15, 2024. Biomerieux Inc. is the prime contractor, and this award does not have a set-aside designation. The FDA, a civilian agency, is the funding...
This is a $148,337.18 firm fixed price purchase order contract awarded by the Department of Health and Human Services Food and Drug Administration to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides a service agreement for two VITEK 2 Compact automated benchtop identification systems used by the FDA's Northeast Food & Feed Laboratory to help identify pathogens in consumer products. The service agreement includes annual preventive maintenance and...
The Food and Drug Administration (FDA) awarded a $283,685.71 firm-fixed-price purchase order contract to Biomerieux Inc. for maintenance services on Biomerieux instruments used by the agency. The contract has a base period of one year and four one-year option periods, through August 2025. Biomerieux Inc. is the sole manufacturer and service provider for the specialized diagnostic equipment and will provide certified technicians to perform repairs and preventative maintenance. The contract was...
This federal contract award is for a Delivery/Task Order under the Food and Drug Administration's (FDA) Biomerieux IDIQ contract. The contract, valued at $39,928.40, was awarded to Biomerieux Inc. for the delivery of products and services to the FDA's New York District Office in Jamaica, NY. The contract has a firm-fixed-price pricing type and a performance period ending on July 28, 2026. Biomerieux Inc., a global leader in in vitro diagnostics, will provide the FDA with its specialized...
Biomerieux Inc. was awarded a $10,038.14 firm fixed price delivery order against the BIOMERIEUX IDIQ contract by the Department of Health and Human Services' Food and Drug Administration. The delivery order was awarded on February 8, 2022 with a completion date of June 8, 2022. The BIOMERIEUX IDIQ contract vehicle provides products and services to the FDA in support of its medical device regulatory and compliance programs. Biomerieux, headquartered in Calverton, Maryland, will be the sole...
The U.S. Food and Drug Administration (FDA) awarded a $9,659.86 firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract, which is not set-aside, provides the FDA with various Biomerieux diagnostic products and consumables, including API 20 E strips, API Listeria, VIDAS Salmonella, VIDAS Listeria, VITEK 2 GN, and VITEK 2 GP. This contract is part of a larger Indefinite Delivery Vehicle (IDV) that...
Biomerieux Inc. was awarded a $17,277.54 firm fixed price delivery order against the Department of Health and Human Services Food and Drug Administration's BIOMERIEUX IDIQ contract vehicle. The delivery order was awarded on December 15, 2021 with a period of performance through July 28, 2026. No set-aside designation was used for this award. Biomerieux Inc. will provide products and services to the FDA from its place of performance in Calverton, Maryland under this delivery order issued...
  • 75F40121D00012
    Indefinite Delivery Contract
  • 75F40121D00012-75F40123F19003
    Delivery Order

The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price delivery order for $10,402.64 to Biomerieux Inc. for annual maintenance and repair of the agency's fleet of Vitek and Vidas equipment. The contract has a period of performance through April 29, 2023 and was awarded on November 7, 2022. No set-aside designation was used for this procurement. Biomerieux Inc. will provide all required products and services from their location in Jamaica, New York to support the FDA's laboratory diagnostic testing programs.

Generated 1/2/24, 1:59 PM